Caxton Associates LLP Amneal Pharmaceuticals, Inc. Put Options Transaction History
Caxton Associates LLP
- $2.87 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMRX
# of Institutions
244Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$118 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$92.5 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$84.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$80.5 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$56.2 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.14B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...